Coronavirus Update: Fujifilm Drug Shows Promise, Arrowhead Halts Trial Screening, Novartis Unveils COVID-19 Measures

First Signs Of Impact on Clinical Trials

Flu drug produces encouraging results in Chinese trials, while Novartis CEO Vas Narasimhan shows his public health background with package of measures.

Apple
The Apple Store in downtown New York, now virtually deserted as the city's inhabitants stay at home to beat COVID-19

Japan’s Fujifilm Holdings Corp. has seen its shares bolt up 15% after a Chinese official said its anti-flu drug Avigan (favipiravir) had clearly helped coronavirus patients recover.

Zhang Xinmin, an official at China’s Science and Technology Ministry, told reporters at a news conference on Tuesday 17 March...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip